Lizandra Paravidine Sasaki

Dr. Lizandra Paravidine Sasaki

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Closed access
Lizandra Paravidine SasakiLizandra Paravidine Sasaki
Lizandra Paravidine Sasaki
KAKeitty Regina Cordeiro Andrade
Keitty Regina Cordeiro Andrade
AFAna Claudia Morais Godoy Figueiredo
Ana Claudia Morais Godoy Figueiredo
MWMiriam da Silva Wanderley
Miriam da Silva Wanderley
MPMaurício G. Pereira
Maurício G. Pereira

21 October 2016 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
MWMiriam da Silva Wanderley
Miriam da Silva Wanderley
MÁMiriam Monteiro Álvares
Miriam Monteiro Álvares
MVMaria de Fátima Brito Vogt
Maria de Fátima Brito Vogt
Lizandra Paravidine SasakiLizandra Paravidine Sasaki
Lizandra Paravidine Sasaki
Objective To evaluate the accuracy of transvaginal ultrasonography, hysteroscopy and uterine curettage in the diagnosis of endometrial polyp, submucous myoma and endometrial hyperplasia, using as gold standard the histopathological analysis of biopsy samples obtained during hysteroscopy or uterine curettage. Methods Cross-sectional study performed at the Hospital Universitário de Brasília (HUB). Data were obtained from the charts of patients submitted to hysteroscopy or uterine curettage in the period from July 2007 to July 2012. Results One-hundred and ninety-one patients were evaluated, 134 of whom underwent hysteroscopy, and 57, uterine curettage. Hysteroscopy revealed a diagnostic accuracy higher than 90% for all the diseases evaluated, while transvaginal ultrasonography showed an accuracy of 65.9% for polyps, 78.1% for myoma and 63.2% for endometrial hyperplasia. Within the 57 patients submitted to uterine curettage, there was an accuracy of 56% for polyps and 54.6% for endometrial hyperplasia. Conclusion Ideally, after initial investigation with transvaginal ultrasonography, guided biopsy of the lesion should be performed by hysteroscopy, whenever necessary, in order to improve the diagnostic accuracy and subsequent clinical management. Objetivo avaliar a acurácia da ultrassonografia transvaginal, da histeroscopia e da curetagem uterina no diagnóstico de pólipo endometrial, mioma submucoso e hiperplasia de endométrio, utilizando como padrão-ouro a análise histopatológica de amostras obtidas por biópsia realizada durante a histeroscopia ou a curetagem. Métodos estudo transversal realizado no Hospital Universitário de Brasília (HUB), cujas informações foram obtidas nos prontuários das pacientes que foram submetidas à histeroscopia ou curetagem uterina no período de julho de 2007 a julho de 2012. Resultados Foram avaliadas 191 pacientes, sendo que 134 foram submetidas à histeroscopia e 57 à curetagem uterina. Observou-se acurácia diagnóstica maior que 90% para todas as patologias avaliadas por histeroscopia, enquanto que por ultrassonografia transvaginal observou-se acurácia de 65,9% para pólipo, 78,1% para mioma e 63,2% para hiperplasia endometrial. Nas 57 pacientes submetidas a curetagem uterina, observou-se acurácia de 56% para pólipo e de 54,6% para hiperplasia endometrial. Conclusão Idealmente, após a investigação inicial com ultrassonografia transvaginal, deveria, sempre que necessário, ser realizada histeroscopia com biópsia guiada da lesão, o que melhoraria a acurácia diagnóstica e posterior conduta clínica.

20 April 2021 in JMIR Research Protocols
Verified
Journal Article
Open access
GFGeraldo Fernandes
Geraldo Fernandes
FMFelipe Motta
Felipe Motta
Lizandra Paravidine SasakiLizandra Paravidine Sasaki
Lizandra Paravidine Sasaki
ÂSÂngelo Pereira Da Silva
Ângelo Pereira Da Silva
AMAndreza Monforte Miranda
Andreza Monforte Miranda
LMLicia Maria Henrique Da Mota
Licia Maria Henrique Da Mota
Background: A growing body of evidence suggests that SARS-COV-2 infection during pregnancy may affect maternal-fetal outcomes and possibly result in implications for the long-term development of SARS-CoV-2–exposed children. Objective: The PROUDEST (Pregnancy Outcomes and Child Development Effects of SARS-CoV-2 Infection Study) is a multicenter, prospective cohort study designed to elucidate the repercussions of COVID-19 for the global health of mothers and their children. Methods: The PROUDEST trial comprises 2 prospective, sequential substudies. The PREGNANT substudy will clinically assess the effects of SARS-CoV-2 infection on pregnancy, childbirth, and puerperium from a mechanistic standpoint to elucidate the pregnancy-related inflammatory and immunological phenomena underlying COVID-19. Pregnant women aged 18-40 years who have been exposed (proven with laboratory tests) to SARS-CoV-2 (group A; n=300) will be compared to control subjects with no laboratory evidence of in-pregnancy exposure to the virus (group B; n=300). Subjects exposed to other infections during pregnancy will be excluded. The BORN substudy is a long-term follow-up study that will assess the offspring of women who enrolled in the prior substudy. It will describe the effects of SARS-CoV-2 exposure during pregnancy on children’s growth, neurodevelopment, and metabolism from birth up to 5 years of age. It includes two comparison groups; group A (exposed; n=300) comprises children born from SARS-CoV-2–exposed pregnancies, and group B (controls; n=300) comprises children born from nonexposed mothers. Results: Recruitment began in July 2020, and as of January 2021, 260 pregnant women who were infected with SARS-CoV-2 during pregnancy and 160 newborns have been included in the study. Data analysis is scheduled to start after all data are collected. Conclusions: Upon completion of the study, we expect to have comprehensive data that will provide a better understanding of the effects of SARS-CoV-2 infection and related inflammatory and immunological processes on pregnancy, puerperium, and infancy. Our findings will inform clinical decisions regarding the care of SARS-CoV-2–exposed mothers and children and support the development of evidence-based public health policies. Trial Registration: Brazilian Register of Clinical Trials RBR65QXS2; https://ensaiosclinicos.gov.br/rg/RBR-65qxs2 International Registered Report Identifier (IRRID): DERR1-10.2196/26477

23 May 2022 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
Lizandra Paravidine SasakiLizandra Paravidine Sasaki
Lizandra Paravidine Sasaki
GFGeraldo Magela Fernandes
Geraldo Magela Fernandes
ASAngelo Pereira da Silva
Angelo Pereira da Silva
FMFelipe Motta
Felipe Motta
CSClara Siracusa
Clara Siracusa
AZAlberto Zaconeta
Alberto Zaconeta
To determine the presence or absence of SARS-CoV-2 in the cerebrospinal fluid of pregnant women at early stages of COVID-19. We conducted a prospective observational study with pregnant women undergoing cesarean section and real-time polymerase chain reaction to SARS-CoV-2 was performed in the cerebrospinal fluid in the early stages of COVID-19. Fourteen pregnant women, whose COVID-19 symptoms started between four to 18 days prior to delivery, were included. Eleven of the women reported anosmia, dysgeusia, and headaches and there were two fatal cases. SARS-Cov-2 was not present in the cerebrospinal fluid of these COVID-19 patients with early neurological symptoms, even in severe cases. Our study suggests that peripheric cell damage and parainfectious phenomena may predominate over direct central nervous system injury in the pathophysiology of COVID-19 related early neurological symptoms on pregnant women.

9 February 2025 in Immunology Letters
Verified
Journal Article
Closed access
Lizandra Paravidine SasakiLizandra Paravidine Sasaki
Lizandra Paravidine Sasaki
MCMaria Eduarda Canellas-De-Castro
Maria Eduarda Canellas-De-Castro
GFGeraldo Magela Fernandes
Geraldo Magela Fernandes
FMFelipe Motta
Felipe Motta
DJDavid Alves Araújo Júnior
David Alves Araújo Júnior
LMLicia Maria Henrique Mota
Licia Maria Henrique Mota

1 January 2025 in Psicologia: Teoria e Pesquisa
Verified
Journal Article
Open access
PDF file
ACAleida Oliveira de Carvalho
Aleida Oliveira de Carvalho
AAAlessandra da Rocha Arrais
Alessandra da Rocha Arrais
YPYácara Ribeiro Pereira
Yácara Ribeiro Pereira
Lizandra Paravidine SasakiLizandra Paravidine Sasaki
Lizandra Paravidine Sasaki
Resumo A pandemia colocou para todos a parentalidade em lugar vulnerável e gerou novos desafios para a vivência da perinatalidade e parentalidade para as mulheres. Este estudo trata-se de uma pesquisa-ação, transversal, de abordagem quantitativa e qualitativa, que apresentará os resultados da fase final da pesquisa, referentes à avaliação dos efeitos do Pré-natal Psicológico (PNP) na redução do sofrimento psíquico materno. Os resultados mostraram-se positivos quanto à eficácia do PNP na prevenção da depressão pós-parto e redução do sofrimento psíquico, no que tange às questões da perinatalidade e parentalidade, mesmo em período de pandemia.